Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.
about
Lactobacillus delbrueckii ssp. bulgaricus B-30892 can inhibit cytotoxic effects and adhesion of pathogenic Clostridium difficile to Caco-2 cellsClostridium difficile toxins: mechanism of action and role in disease.Clindamycin as an antimalarial drug: review of clinical trials.Epidemiologic background of hand hygiene and evaluation of the most important agents for scrubs and rubsSystematic review and meta-analysis of Saccharomyces boulardii in adult patientsClostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003Bench-to-bedside review: Clostridium difficile colitisClostridium difficile in the ICU: the struggle continuesNon-systemic drugs: a critical reviewConformational analysis of Clostridium difficile toxin B and its implications for substrate recognitionAssociation between NSAIDs and Clostridium difficile-Associated Diarrhea: A Systematic Review and Meta-AnalysisAntimicrobial Resistance and Reduced Susceptibility in Clostridium difficile: Potential Consequences for Induction, Treatment, and Recurrence of C. difficile InfectionFecal microbiota transplantation: current status and future directionsNeutralization of Clostridium difficile toxin A with single-domain antibodies targeting the cell receptor binding domainUse of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trialAssessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.The challenges posed by reemerging Clostridium difficile infection.Antibacterial Resistance in Patients with Hematopoietic Stem Cell Transplantation.A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection.Role of retinol in protecting epithelial cell damage induced by Clostridium difficile toxin A.Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011.Learning Data-Driven Patient Risk Stratification Models for Clostridium difficile.Moving fecal microbiota transplantation into the mainstream.Hospital-acquired Clostridium difficile-associated disease in the intensive care unit setting: epidemiology, clinical course and outcomeTyping Clostridium difficile strains based on tandem repeat sequences.Evolutionary clade affects resistance of Clostridium difficile spores to Cold Atmospheric Plasma.Piglet models of acute or chronic Clostridium difficile illness.Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activityClostridium difficile extracytoplasmic function σ factor σV regulates lysozyme resistance and is necessary for pathogenesis in the hamster model of infection.Economic burden of healthcare-associated infections: an American perspective.Risk factors for Clostridium difficile infections - an overview of the evidence base and challenges in data synthesis.Analysis of the unexplored features of rrs (16S rDNA) of the Genus Clostridium.The impact of hospital-onset Clostridium difficile infection on outcomes of hospitalized patients with sepsis.Clostridium difficile Infections: What Every Clinician Should KnowProfound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis.Antibiotics for Treatment of Clostridium difficile Infection in Hospitalized Patients with Inflammatory Bowel DiseaseMortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in QuebecIn vitro activity of OPT-80 against Clostridium difficile.A Clostridium difficile infection "intervention": change in toxin assay results in fewer C difficile infection cases without changes in patient outcomes.Inhibiting the initiation of Clostridium difficile spore germination using analogs of chenodeoxycholic acid, a bile acid.
P2860
Q21198789-D3C30AEE-A5D6-4374-80D8-A61DD061C14EQ24522454-B0D409E3-9401-41B1-B2EA-E98EDF6E2F16Q24536057-290B201F-4D96-4E41-B707-CC9C3C713CD5Q24562996-CA284980-EB26-4205-A797-E5DF0DE31D3FQ24621081-040D8DE7-44A5-47E9-986F-DA4BD696D310Q24627863-D7BFFDAD-9D68-49C2-BD66-08C8AAAAB7D6Q24644191-8A29EC08-A3F8-41A2-BC17-4B0161D0FA39Q26823000-36BAA03F-83AE-4351-ABB0-7C30BDCCF823Q26863371-24A8FE08-3D71-430C-B4E7-FDBB8A241AE5Q27331744-08F1DEAB-0FE2-403E-9FC0-60EBC4418912Q28072682-5360D27F-5A96-4288-BDCA-6B24D686AF9AQ28084026-0675DAC8-589B-4F55-96B8-E0471FFB7409Q28251016-95F3BDBD-2D26-4D67-8115-25709CB064B2Q28302768-05E03B30-5666-41B8-B383-44ABE2F558C3Q29394639-835C5F58-0A62-41AB-80FF-B8354F2A7C8AQ30229124-BA45B365-EEFE-4598-87C9-E52DB53585CEQ30229530-11BA7B1B-4D72-4DC0-AACC-1F6C18399DD0Q30238945-52B480D8-7494-4108-8CB7-CA3B651CBBA5Q30437722-C69B2AD6-39A8-4D14-B3BF-0B69804DC8BEQ30440630-BEF548CE-5DC8-4249-B343-7115D389D04DQ30605607-A3536FD6-6550-4807-9899-431A24EFEF7AQ30903148-7495730C-6AFE-447A-8106-856867BAE02DQ31127164-76C6428E-A0C0-405F-948A-224244CFBB2EQ33285304-E7AD1BD6-5EDE-4308-835D-97BA533F90E7Q33398660-A5461C6C-1499-4C2B-95FA-EB1380C576C9Q33469737-7A6E21EF-900F-418D-BDCC-D8FAEB2E82B4Q33583467-C2ABB900-6F43-40E9-A74A-3012352250CBQ33584866-8624E1D0-578D-4319-84FB-EAFFE6C89E87Q33603104-835C96E5-73DF-4441-957E-44A8F226EC68Q33685288-D5C5A269-CB86-48C3-82EC-6F82819B5B66Q33767958-53FE8DD3-402D-42B2-89B3-6865064299E0Q33790436-0C61E9EA-0288-4212-BE78-2EA86F0C5CB2Q33838644-0BCB11F7-BCA7-4873-BB34-B0D16BF9D9ACQ34028301-B865455E-8296-4550-A218-8DD1F5D5B3EEQ34050235-DE5A79BC-3E6E-438B-A9F1-19576C59B452Q34057490-4D9D8C6C-9AA4-47A4-86A0-D2C774755AD2Q34099215-919717BD-03A7-496D-9ADA-FFA762EB8C51Q34142125-2E95385D-7BD0-4B52-8901-60AC08E718B2Q34142574-D87F59A8-08C6-41E0-A120-1003CA56BB79Q34150754-6104B34A-4A2F-42F0-B42E-215364AA389D
P2860
Health care costs and mortality associated with nosocomial diarrhea due to Clostridium difficile.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Health care costs and mortalit ...... due to Clostridium difficile.
@en
Health care costs and mortalit ...... due to Clostridium difficile.
@nl
type
label
Health care costs and mortalit ...... due to Clostridium difficile.
@en
Health care costs and mortalit ...... due to Clostridium difficile.
@nl
prefLabel
Health care costs and mortalit ...... due to Clostridium difficile.
@en
Health care costs and mortalit ...... due to Clostridium difficile.
@nl
P2093
P2860
P356
P1476
Health care costs and mortalit ...... due to Clostridium difficile.
@en
P2093
Ciarán P Kelly
Lorraine Kyne
Mary Beth Hamel
Rajashekhar Polavaram
P2860
P304
P356
10.1086/338260
P407
P577
2001-12-17T00:00:00Z